Please login to the form below

Not currently logged in
Email:
Password:

Sanofi/Rib-X antibiotic collaboration

Sanofi has announced it is to partner with Rib-X Pharmaceuticals to research new classes of antibiotic therapies

Sanofi has announced it is to partner with Rib-X Pharmaceuticals to research new classes of antibiotic therapies.

The deal will see Rib-X receive a $10m upfront payment, with the potential for a further $9m in near-term research-based milestones as well as future regulatory and commercial milestsones.

According to Sanofi, the agreement could result in up to $186m in total milestone payments for Rib-X on a per product basis.

In return, Sanofi will hold the licence to any assets developed using Rib-X's RX-04 programme as part of the deal, with Sanofi able to develop multiple products.

The RX-04 programme is used to develop antibiotics for the treatment of Gram-negative and Gram-positive pathogens, and has shown success in treating multi-drug resistant strains.

"The clinical need for new antibiotics is reaching crisis level, yet the antibiotic pipeline is running dry and fewer and fewer companies are working to develop drugs in this space," said Dr Elias Zerhouni, president, global research and development at Sanofi. "This partnership exemplifies Sanofi's commitment to translate novel approaches for treatment into patient solutions addressing the global critical need to combat the rising threat of antibiotic drug resistance."

6th July 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Serviceplan Health & Life

We are your creative global lead agency, your Pan-European hub and your worldwide network....

Latest intelligence

‘Give our Dad a Bone’. It’s That Simple
The Give our Dad a Bone campaign had no grand strategy, no planning meetings, timelines, deep insight or client brief, just one overriding – and life-saving – key message: join...
Is telehealth delivering on its promises?
Using new digital technologies to help patients see their doctors online and not need to attend their surgery can help save time and money - but just how well is...
Channel purpose, change lives
GCI Health's Laura Starr on the power of creativity in health and wellness, all founded upon authentic brand purpose....

Infographics